Published in Telemedicine Business Week, October 18th, 2006
Of the 36 patients enrolled in the U.S. Food and Drug Administration (FDA) approved trial, interim results were reported on 23 patients, including 12 patients who completed the total trial observation period of 12 months by August 2006. Of the 12 patients who have completed the 1 year follow-up period, 10 showed bone bridging at the fracture site, indicating radiographic evidence of healing.
At this time, two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week